Inside informationEnglish
Press Release: Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 13/01/2025, 07:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 112694_20250113